Post-approval studies (Phase 4)UnknownNCT03648554
What this trial is testing
Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic Steatohepatitis
Central Hospital, Nancy, France 93